Global Tissue Heart Valves Market Research Report 2021

Tissue or biological heart valve is made from animal tissue, such as porcine (pig) or bovine (cow), as it is similar to human tissue. Tissue heart valves need chemical treatment for protection and stent or frame for support. Tissue heart valves can last up to 10 to 20 years.
The global tissue heart valves market is expected to grow substantially due to high prevalence of heart valve diseases, which is constantly rising due to socioeconomic factors, such as lifestyle-induced dietary, physical inactivity, and certain other habits, including smoking. Moreover, longer life expectancy of the geriatric population boosts the growth of the tissue heart valves market. As per a report of the National Institutes of Health (NIH), 8.5% of the world population is aged 65 or above, and it is anticipated to rise to nearly 17% by 2050. In addition, increase in demand for minimally invasive procedures and technological advancements are projected to propel the growth of the tissue heart valves market during the forecast period. On the other hand, stringent government approval process and high price of minimally invasive procedures are hindering the market growth. Nevertheless, huge unmet needs in the emerging markets and advanced treatment of valvular diseases are expected to create opportunities for the tissue heart valve market.

The global Tissue Heart Valves market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Tissue Heart Valves volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Tissue Heart Valves market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Tissue Heart Valves Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Stented Tissue Heart Valves
Stentless Tissue Heart Valves

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Edwards Lifesciences
Medtronic
Abbott
Abbott
Colibri Heart Valve
CryoLife
Labcor Laboratorios